Delivery Order SPE2DB24D2011-SPE2DB24FBPVA

Award Date 5/20/24
Potential Completion Date 5/21/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product, with a potential value of $5,589.16 and a completion date of February 14, 2024. The contract is not set aside for any specific business type....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $2,944.68. The contract is a firm fixed price Delivery Order with an ultimate completion date of May 8, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,885.78 firm fixed price delivery order contract to provide VYVANSE 30 MG CAPSULE 100S. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a supplier of pharmaceutical products and medical supplies to various U.S. government agencies, primarily the Department of Defense....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The contract, valued at $4,814.92, was awarded by the Defense Logistics Agency (DLA), a defense agency, as a firm-fixed-price delivery order contract. The contract has an ultimate completion date of June 24, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award, valued at $1,293.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product, to support military treatment programs and facilities. The award is a firm fixed price delivery order with an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp, through its Corporate...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,110.55 firm fixed-price contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,700.16 firm-fixed-price delivery order is for the supply of VYVANSE 70 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of VYVANSE 30 MG CAPSULES, a pharmaceutical product, with a firm fixed price of $4,133.23 and a completion date of March 7, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract awards from DLA Troop Support...
This $1,554.47 firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565888957 - VYVANSE 60 MG CAPSULE 100S, a pharmaceutical product. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting military treatment facilities, veterans' hospitals, and other federal...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The award has a ceiling value of $7,067.84 and a period of performance through March 12, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which is part of a larger indefinite delivery contract...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBPVA
    Delivery Order

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $3,123.75, is for the provision of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This contract award does not have a set-aside designation.

Generated 8/25/24, 12:25 AM